PATENT CLAIM ANALYSIS

Application Number: 16003600
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-02
Patent Classification: ["514", "220000"]

Abstract:
The present invention relates to tricyclic quinoline and quinoxaline derivatives, to a pharmaceutical composition containing such compounds, to their use as modulators, especially agonists or partial agonists, of the 5-HT 2C  receptor, their use for preparing a medicament for the prevention or treatment of conditions and disorders which respond to the modulation of 5-HT 2C  receptor, and to a method for preventing or treating conditions and disorders which respond to the modulation of 5-HT 2C  receptor.

Claim (Index 52):
A pharmaceutical composition comprising a therapeutically effective amount of at least one compound as claimed in  claim 51 , or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof in combination with at least one pharmaceutically acceptable carrier and/or auxiliary substance.

Metadata:
- Claim Count in Document: 140.0
- Percentile: 94.0
- Lexical Diversity: 1.88636
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14026354', '13838788', '14868835', '14657916', '14657840']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7273997518735448
- 35 USC 102 Novelty (BERT): 0.5201543314393086
- Combined Prediction Score: 0.7066752098301212
- Mean Citation Score: 284.69573
- Max Citation Score: 312.41757
- Similarity Product: 255.26358122353253

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test